The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer

20243 citationsJournal Articlegold Open Access

Authors

The serum VEGF-A121/165 ratio may represent a new, easily measured biomarker for predicting the therapeutic response to ICIs.

Good health and well-being

Published in: Cancers

Volume 16, Issue 23, pp. 3958-3958

Field-Weighted Citation Impact: 1.26